This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.

Screening Protocol for Genetic Diseases of Allergic Inflammation | MicrobiomeTrials

NCT00852943

Screening Protocol for Genetic Diseases of Allergic Inflammation

CompletedOBSERVATIONAL

Trial Details

Start: 2010-11-02

Enrollment target: 824 participants

Locations

National Institutes of Health Clinical Center, Bethesda, Maryland, United States

DysphagiaEosinophilic Esophagitis

Background: Eosinophilic esophagitis (EoE) is a disease that causes inflammation in the esophagus. The esophagus is the…

Bethesda, United StatesEst. completion Aug 31, 2027

Bullous Pemphigoid (BP)

Bullous pemphigoid is an autoimmune subepidermal blistering disease characterized by eosinophilic inflammation and varia…

Istanbul, Turkey (Türkiye)Est. completion Dec 24, 2026

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.